Pharmacologic therapies for diabetic retinopathy and diabetic macular edema

Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of blindness in the working-aged population of most developed countries. The increasing number of persons with diabetes worldwide suggests that DR/DME will continue to be major contributors to vision loss and associated fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rechtman, Ehud, Harris, Alon, Garzozi, Hanna J, Ciulla, Thomas A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704543/
https://www.ncbi.nlm.nih.gov/pubmed/19668515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704543/
https://www.ncbi.nlm.nih.gov/pubmed/19668515

Ejemplares similares